A note on the Hybrid Soil Moisture Deficit Model v2.0

peer-reviewedThe Hybrid Soil Moisture Deficit (HSMD) model has been used for a wide range of applications, including modelling of grassland productivity and utilisation, assessment of agricultural management opportunities such as slurry spreading, predicting nutrient emissions to the environment and risks of pathogen transfer to water. In the decade since its publication, various ad hoc modifications have been developed and the recent publication of the Irish Soil Information System has facilitated improved assessment of the spatial soil moisture dynamics. In this short note, we formally present a new version of the model (HSMD2.0), which includes two new soil drainage classes, as well as an optional module to account for the topographic wetness index at any location. In addition, we present a new Indicative Soil Drainage Map for Ireland, based on the Irish Soil Classification system, developed as part of the Irish Soil Information System

Abiotic Stress Mitigation: A Case Study from 21 Trials Using a Natural Organic Matter Based Biostimulant Across Multiple Geographies

Crop productivity and yields can be greatly diminished by abiotic stress events including drought, extreme temperatures, excess moisture, and saline irrigation water. Multiple stressors occurring simultaneously can further exacerbate the strain on plants. Various types of biostimulants have been shown to mitigate abiotic stress and here, the results of 21 trials on corn, wheat, soybean, and various high-value crops are discussed in the context of the abiotic stress that either occurred naturally or was experimentally induced. Treatments in these trials included stressed and non-stressed plants, as well as either an untreated control or grower standard fertilizer applications alone and in combination with a natural organic matter (NOM)-based biostimulant. While stressed plants suffered compared with non-stressed plants, the stressed plants receiving the NOM-based biostimulant were healthier and larger, as indicated by whole, root, and shoot weights and yields at harvest. Plant response was stronger when stress existed, but the biostimulant also led to healthier plants when no stress occurred. Positive results occurred for 20 of the 21 trials, indicating that biostimulants can effectively mitigate abiotic stress events regardless of the plant species tested or the growing conditions encountered, by increasing sap Brix, enzymatic activity, and nutrient use efficiency

Rapid Sub-nanomolar Protein Determination in Serum using Electropolymerized Molecularly Imprinted Polymers (E-MIPs)

Rapid detection of biologicals is important for a range of applications such as medical screening and diagnostics. Antibodies are typically employed for biosensing with high sensitivity and selectivity but can take months to prepare. Here, we investigate electropolymerized molecularly imprinted polymers (E-MIPs), which are produced in minutes as alternative-antibody rapid biosensors for the selective recognition of model proteins bovine haemoglobin (BHb) and bovine serum albumin (BSA). We evaluated two disposable screen-printed electrodes (SPE) designated AT-Au and BT-Au based on their different annealing temperatures. E-MIPs for BHb demonstrated an imprinting factor of 146:1 at 1nM and 12:1 at 0.1nM, showing high effectiveness of E-MIPs compared to their control non-imprinted polymers. The BHb imprinted E-MIP, when tested against BSA as a non-target protein, gave a selectivity factor of 6:1 for BHb. Sensor sensitivity directly depended on the nature of the SPE, with AT-Au SPE demonstrating limits of detection in the sub-micromolar range typically achieved for MIPs, while BT-Au SPE exhibited sensitivity in the sub-nanomolar range for target protein. We attribute this to differences in electrode surface area between AT-Au and BT-Au SPEs. The E-MIPs were also tested in calf serum as a model biological medium. The BT-Au SPE MIPs detected the presence of target protein in < 10 min with an LOD of 50 pM and LOQ of 100 pM, suggesting their suitability for protein determination in serum with minimal sample preparation. Using electrochemical impedance spectroscopy, we determine equilibrium dissociation constants (KD) for E-MIPs using the Hill-Langmuir adsorption model. KD of BHb E-MIP was determined to be 0.86 ± 0.11nM

Magnetic nanoparticle-facilitated rapid mass production of high affinity polymeric materials (nanoMIPs) for protein recognition and biosensing †

Molecularly imprinted polymers (MIPs) have been investigated extensively for broad applications in diagnostics, imaging and therapeutics due to their antibody-like specificity, high stability, and low-cost and rapid production when compared with biological antibodies. Yet, their wide-scale adoption and commercial viability are limited due to low yields and relatively lengthy preparations of current methods. We report the novel application of protein-functionalised magnetic nanoparticles (MNPs) to enable the rapid mass production of nanoMIPs for protein recognition. An aldehyde-functionalised MNP (MNP@CHO) precursor was synthesised using a one-pot microwave method in less than 20 minutes, resulting in 330 mg yield for a 30 mL reaction volume. The MNP@CHO precursor (10 mg) was subsequently functionalised with 600 μg of a target template protein, giving MNP@protein. In the presence of an N-hydroxymethylacrylamide (NHMA) functional monomer and N, N′-methylene bisacrylamide as a crosslinker, the MNP@protein particles served as nucleants for the mass production of nanoMIPs in a 20–30 minute synthesis process. Subsequently, the nanoMIPs could be harvested with sonication and then retrieved using a magnet, leaving the MNP@protein particles to be recycled and re-used at least 5 times for further nanoMIP production cycles. In general, 10 mg of MNP@protein produced 10 mg of nanoMIP with a 20% decrease in the yield over the 5 synthesis cycles. For the bovine haemoglobin nanoMIP, the KD was determined to be 3.47 × 10−11 M, a binding affinity rivalling values found for monoclonal antibodies. We also demonstrate that the methodology is generic by producing high-affinity nanoMIPs for other proteins including albumin, lysozyme and SARS-CoV-2 recombinant protein. We therefore present a facile route to produce nanoMIPs in large industrially relevant quantities (hundreds of mg) and at short timescales (within a day). Our method offers realistic opportunities for the industry to adopt such materials as an antibody replacement technology in diagnostics, biological extraction and therapeutics

Mapping Soils in Ireland

peer-reviewedThis project is jointly funded by Teagasc and EPA STRIVE funding.Harmonised soil data across Europe with a 1:250 000 geo-referenced soil database will allow for exchange of data across member states and the provide the information needed for reporting on issues re-lating to soil quality under a future Soil Framework Directive. The current status of soils data available in Eu-rope is inconsistent at best. The Irish Soil Information System (ISIS) project is currently developing a national soil map of 1:250,000 and an associated digital soil information system, providing both spatial and quantita-tive information on soil types and properties across Ireland. Both the map and the information system will be freely available to the public through a designated website.This project is jointly funded by Teagasc and EPA STRIVE funding

APOΕ4 Lowers Energy Expenditure in Females and Impairs Glucose Oxidation by Increasing Flux through Aerobic Glycolysis

BACKGROUND: Cerebral glucose hypometabolism is consistently observed in individuals with Alzheimer\u27s disease (AD), as well as in young cognitively normal carriers of the Ε4 allele of Apolipoprotein E (APOE), the strongest genetic predictor of late-onset AD. While this clinical feature has been described for over two decades, the mechanism underlying these changes in cerebral glucose metabolism remains a critical knowledge gap in the field. METHODS: Here, we undertook a multi-omic approach by combining single-cell RNA sequencing (scRNAseq) and stable isotope resolved metabolomics (SIRM) to define a metabolic rewiring across astrocytes, brain tissue, mice, and human subjects expressing APOE4. RESULTS: Single-cell analysis of brain tissue from mice expressing human APOE revealed E4-associated decreases in genes related to oxidative phosphorylation, particularly in astrocytes. This shift was confirmed on a metabolic level with isotopic tracing of 13C-glucose in E4 mice and astrocytes, which showed decreased pyruvate entry into the TCA cycle and increased lactate synthesis. Metabolic phenotyping of E4 astrocytes showed elevated glycolytic activity, decreased oxygen consumption, blunted oxidative flexibility, and a lower rate of glucose oxidation in the presence of lactate. Together, these cellular findings suggest an E4-associated increase in aerobic glycolysis (i.e. the Warburg effect). To test whether this phenomenon translated to APOE4 humans, we analyzed the plasma metabolome of young and middle-aged human participants with and without the Ε4 allele, and used indirect calorimetry to measure whole body oxygen consumption and energy expenditure. In line with data from E4-expressing female mice, a subgroup analysis revealed that young female E4 carriers showed a striking decrease in energy expenditure compared to non-carriers. This decrease in energy expenditure was primarily driven by a lower rate of oxygen consumption, and was exaggerated following a dietary glucose challenge. Further, the stunted oxygen consumption was accompanied by markedly increased lactate in the plasma of E4 carriers, and a pathway analysis of the plasma metabolome suggested an increase in aerobic glycolysis. CONCLUSIONS: Together, these results suggest astrocyte, brain and system-level metabolic reprogramming in the presence of APOE4, a \u27Warburg like\u27 endophenotype that is observable in young females decades prior to clinically manifest AD

Development of measures to evaluate youth advocacy for obesity prevention

BACKGROUND: Youth advocacy has been successfully used in substance use prevention but is a novel strategy in obesity prevention. As a precondition for building an evidence base for youth advocacy for obesity prevention, the present study aimed to develop and evaluate measures of youth advocacy mediator, process, and outcome variables. METHODS: The Youth Engagement and Action for Health (YEAH!) program (San Diego County, CA) engaged youth and adult group leaders in advocacy for school and neighborhood improvements to nutrition and physical activity environments. Based on a model of youth advocacy, scales were developed to assess mediators, intervention processes, and proximal outcomes of youth advocacy for obesity prevention. Youth (baseline n = 136) and adult group leaders (baseline n = 47) completed surveys before and after advocacy projects. With baseline data, we created youth advocacy and adult leadership subscales using confirmatory factor analysis (CFA) and described their psychometric properties. RESULTS: Youth came from 21 groups, were ages 9–22, and most were female. Most youth were non-White, and the largest ethnic group was Hispanic/Latino (35.6 %). The proposed factor structure held for most (14/20 youth and 1/2 adult) subscales. Modifications were necessary for 6 of the originally proposed 20 youth and 1 of the 2 adult multi-item subscales, which involved splitting larger subscales into two components and dropping low-performing items. CONCLUSIONS: Internally consistent scales to assess mediators, intervention processes, and proximal outcomes of youth advocacy for obesity prevention were developed. The resulting scales can be used in future studies to evaluate youth advocacy programs

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Patients with chronic kidney disease (CKD) are predisposed to heart rhythm disorders, including atrial fibrillation (AF)/atrial flutter, supraventricular tachycardias, ventricular arrhythmias, and sudden cardiac death (SCD). While treatment options, including drug, device, and procedural therapies, are available, their use in the setting of CKD is complex and limited. Patients with CKD and end-stage kidney disease (ESKD) have historically been under-represented or excluded from randomized trials of arrhythmia treatment strategies,1 although this situation is changing.2 Cardiovascular society consensus documents have recently identified evidence gaps for treating patients with CKD and heart rhythm disorders [...